Yseop Secures Investment to Accelerate Generative AI Content Automation for Pharma
Yseop, a world-leading Generative AI company for life sciences, today announces the closing of a strategic investment round, with new investor Novartis (dRx Capital
Stay updated with breaking news from Yseop Copilot. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Yseop, a world-leading Generative AI company for life sciences, today announces the closing of a strategic investment round, with new investor Novartis (dRx Capital
Today, world-leading generative artificial intelligence (AI) company for life sciences, Yseop, is celebrating its involvement in more than 150 clinical trials with pharma giants around the world.
Another company OSP was lucky enough to catch up with at DIA Global in Boston this year, was well-established generative artificial intelligence (AI) software company, Yseop.
According to the company, this generative AI offering aims to assist life sciences firms in streamlining their automation requirements